MKC vs TSHA · P/E 8.4, rev $3.81B vs $640.7M cap
McCormick & Company Incorporated (MKC) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
MKC currently screens at market cap $13.56B and trailing P/E 8.4. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the MKC and TSHA stock pages for the full models.
Not investment advice.